A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit.

65% sensitivity of upper airway swab RT-PCR tests


Leave a Reply

Your email address will not be published. Required fields are marked *